PRCT - PROCEPT BioRobotics Corporation Stock Price, Fair Value and News

$94.02-0.43 (-0.46%)

Delayed as of 22 Nov 2024, 11:10 am ET

Max Portfolio Pct.

Check

Valuation

Check

Stock Quality:

Max Portfolio Pct.

Check

Valuation

Check

PRCT Price Action

Last 7 days

9.9%

Last 30 days

38.6%

Last 90 days

19.0%

Trailing 12 Months

172.0%

PRCT RSI Chart

PRCT Valuation

Market Cap

4.9B

Price/Earnings (Trailing)

-49.26

Price/Sales (Trailing)

24.66

Price/Free Cashflow

-47.59

PRCT Price/Sales (Trailing)

The Good, Bad and Ugly

Growth

Profitability

Size

Dilution Risk

Balance Sheet

Momentum

Funds Popularity

Insider Trading

PRCT Fundamentals

PRCT Revenue

Revenue (TTM)

199.8M

Rev. Growth (Yr)

66.29%

Rev. Growth (Qtr)

9.4%

PRCT Earnings

Earnings (TTM)

-100.1M

Earnings Growth (Yr)

14.82%

Earnings Growth (Qtr)

18.15%

PRCT Profitability

Operating Margin

57.39%

Return on Equity

-41.48%

Return on Assets

-26.74%

Free Cashflow Yield

-2.1%

PRCT Investor Care

Shares Dilution (1Y)

3.34%

Diluted EPS (TTM)

-1.95

Revenue & Growth

Historical Charts for Stock Metrics

Get all data in R, Python etc through our Historical Stock Data APIs

Net sales

Year	Q1	Q2	Q3	Q4
2024	156.3M	176.6M	199.8M	0
2023	85.2M	101.6M	116.4M	136.2M
2022	41.5M	49.7M	61.4M	75.0M
2021	14.4M	21.1M	27.8M	34.5M
2020	0	0	0	7.7M

Get all data in R, Python etc through our Historical Stock Data APIs

About PROCEPT BioRobotics Corporation

PROCEPT BioRobotics Corporation, a surgical robotics company, develops transformative solutions in urology. It develops, manufactures, and sells AquaBeam Robotic System, an image-guided, surgical robotic system for use in minimally invasive urologic surgery with a focus on treating benign prostatic hyperplasia (BPH). The company also designs Aquablation therapy for males suffering from lower urinary tract symptoms due to BPH. PROCEPT BioRobotics Corporation was incorporated in 2007 and is headquartered in Redwood City, California.

CEO	Dr. Reza Zadno Ph.D.
WEBSITE	procept-biorobotics.com
SECTOR	Healthcare
INDUSTRY	Medical Devices
EMPLOYEES	428

PROCEPT BioRobotics Corporation Frequently Asked Questions

What is the ticker symbol for PROCEPT BioRobotics Corporation? What does PRCT stand for in stocks?

PRCT is the stock ticker symbol of PROCEPT BioRobotics Corporation. Every public company that trades on a stock exchange gets a ticker symbol.

What is the market capital of PROCEPT BioRobotics Corporation (PRCT)?

As of Thu Nov 21 2024, market cap of PROCEPT BioRobotics Corporation is 4.93 Billion. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.

What is the fair value of PRCT stock?

You can check PRCT's fair value in chart for subscribers.

Is PROCEPT BioRobotics Corporation a good stock to buy?

The fair value guage provides a quick view whether PRCT is over valued or under valued. Whether PROCEPT BioRobotics Corporation is cheap or expensive depends on the assumptions which impact PROCEPT BioRobotics Corporation's fair value. We provide several scenarios of inflation and growth to encompass these range of assumptions for PRCT.

What is PROCEPT BioRobotics Corporation's Price to Earnings (PE) and Price to sales (PS) ratio?

As of Thu Nov 21 2024, PRCT's PE ratio (Price to Earnings) is -49.26 and Price to Sales (PS) ratio is 24.66. The price to earnings and price to sales ratio are two most important valuation metrics for any company. PE ratio tell us the number of years of earnings investors are ready to pay for owning the company. Historically, S&P500 price to earnings ratio has fallen below 12 during periods of gloom and gone past 30 during periods of euphoria. PRCT PE ratio will change depending on the future growth rate expectations of investors.